Loading company…
U-Synbio is developing oral live biotherapeutic products for tumor prevention and treatment.
U-Synbio is developing a synthetic biology platform for oral live biotherapeutic products that may be used to prevent and treat tumors. Founded in 2021, the company is based in Suzhou, China. Its founder is Dr. Jingyu Chen, and its CTO is Guoqiang Chen.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in